INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE

Clinical trial NCT03871517 · COMPLETED

Trial details

NCT number: NCT03871517
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ischemic Stroke Indobufen Aspirin

Start date: 2019-06-03
Primary completion: 2022-03-01
Enrollment: 5438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.